BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 925956)

  • 1. Effect of the duration of infusion on the disposition of lidocaine in dogs.
    LeLorier J; Moisan R; Gagné J; Caillé G
    J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the pharmacokinetics of alfentanil in rabbits, sheep, and dogs.
    Ilkiw JE; Benthuysen JA; McNeal D
    Am J Vet Res; 1991 Apr; 52(4):581-4. PubMed ID: 2053728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
    Sawyer DR; Ludden TM; Crawford MH
    Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
    Gugler R; Lain P; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):416-23. PubMed ID: 1195128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of duration of infusion on elimination rate of alfentanil].
    Castor G; Altmayer P; Venitz J
    Anaesthesiol Reanim; 1995; 20(4):97-100. PubMed ID: 7575958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram.
    McAllister RG; Bourne DW; Dittert LW
    J Pharmacol Exp Ther; 1977 Jul; 202(1):38-44. PubMed ID: 874818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. I. Effects of continuous infusion.
    Tam YK; Yau M; Berzins R; Montgomery PR; Gray M
    Drug Metab Dispos; 1987; 15(1):12-6. PubMed ID: 2881747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of enhanced alpha-1-acid glycoprotein concentration on protein binding, pharmacokinetics and antiarrhythmic effect of lidocaine in the dog.
    De Rick AF; Belpaire FM; Dello C; Bogaert MG
    J Pharmacol Exp Ther; 1987 Apr; 241(1):289-93. PubMed ID: 3572791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of bupivacaine after short and prolonged infusions in conscious dogs.
    Mazoit JX; Lambert C; Berdeaux A; Gerard JL; Froideveaux R
    Anesth Analg; 1988 Oct; 67(10):961-6. PubMed ID: 3421499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of the pharmacokinetics of lidocaine.
    Benowitz NL
    Cardiovasc Clin; 1974; 6(2):77-101. PubMed ID: 4613465
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of heparin. II. Studies of time dependence in rats.
    Bjornsson TD; Levy G
    J Pharmacol Exp Ther; 1979 Aug; 210(2):243-6. PubMed ID: 458631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.
    LeLorier J; Grenon D; Latour Y; Caillé G; Dumont G; Brosseau A; Solignac A
    Ann Intern Med; 1977 Dec; 87(6):700-2. PubMed ID: 931206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of gastrointestinal tract disease on pharmacokinetics of lidocaine after intravenous infusion in anesthetized horses.
    Feary DJ; Mama KR; Thomasy SM; Wagner AE; Enns RM
    Am J Vet Res; 2006 Feb; 67(2):317-22. PubMed ID: 16454639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of thiamylal in cats.
    Wertz EM; Benson GJ; Thurmon JC; Tranquilli WJ; Davis LE; Koritz GD
    Am J Vet Res; 1988 Jul; 49(7):1079-83. PubMed ID: 3421532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination.
    Saville BA; Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):17-21. PubMed ID: 2881753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of epsilon-aminocaproic acid in horses.
    Ross J; Dallap BL; Dolente BA; Sweeney RW
    Am J Vet Res; 2007 Sep; 68(9):1016-21. PubMed ID: 17764418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.